Literature DB >> 11042588

B2 bradykinin receptor immunoreactivity in rat brain.

E Y Chen1, D F Emerich, R T Bartus, J H Kordower.   

Abstract

Bradykinin has long been known to exist in the central nervous system and has been hypothesized to mediate specific functions. Despite an increasing understanding of the functions of bradykinin, little is known about the cell types expressing the bradykinin receptor within the brain. The present investigation employed a monoclonal antibody directed against the 15-amino-acid portion of the C-terminal of the human bradykinin B2 receptor to establish the cellular distribution of bradykinin B2 receptor immunoreactivity in the rat brain. Bradykinin B2 receptor immunoreactivity was ubiquitously and selectively observed in neurons, including those within the olfactory bulb, cerebral cortex, hippocampus, basal forebrain, basal ganglia, thalamus, hypothalamus, cerebellum, and brainstem nuclei. Bradykinin B2 receptor immunoreactivity was also present in the circumventricular organs including choroid plexus, subfornical organ, median eminence, and area postrema. Double-labeling experiments colocalizing the bradykinin B2 receptor with the neuronal marker NeuN or the astrocytic marker glial fibrillary acidic protein revealed that virtually 100% of the bradykinin B2 receptor-immunoreactive positive cells were neurons. The widespread distribution of bradykinin B2 receptor immunoreactivity in neuronal compartments suggests a greater than previously appreciated role for this peptide in neuronal function. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11042588

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  17 in total

1.  Taking the sting out of pain.

Authors:  I Nagy; C Paule; J White; L Urban
Journal:  Br J Pharmacol       Date:  2007-05-29       Impact factor: 8.739

2.  Astrocytic connectivity in the hippocampus.

Authors:  Jai-Yoon Sul; George Orosz; Richard S Givens; Philip G Haydon
Journal:  Neuron Glia Biol       Date:  2004-02

3.  Cloning, structural characterization and functional expression of a zebrafish bradykinin B2-related receptor.

Authors:  Torun Dunér; J Michael Conlon; Jyrki P Kukkonen; Karl E O Akerman; Yi-Lin Yan; John H Postlethwait; Dan Larhammar
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

4.  The role of bradykinin B(1) and B(2) receptors for secondary brain damage after traumatic brain injury in mice.

Authors:  Raimund Trabold; Christian Erös; Klaus Zweckberger; Jane Relton; Heike Beck; Juerg Nussberger; Werner Müller-Esterl; Michael Bader; Eric Whalley; Nikolaus Plesnila
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-23       Impact factor: 6.200

5.  Bradykinin-induced astrocyte-neuron signalling: glutamate release is mediated by ROS-activated volume-sensitive outwardly rectifying anion channels.

Authors:  Hong-Tao Liu; Tenpei Akita; Takahiro Shimizu; Ravshan Z Sabirov; Yasunobu Okada
Journal:  J Physiol       Date:  2009-02-02       Impact factor: 5.182

6.  The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q.

Authors:  Maria Grazia De Simoni; Emanuela Rossi; Claudio Storini; Simone Pizzimenti; Cinara Echart; Luigi Bergamaschini
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

7.  LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia.

Authors:  Li Ding-Zhou; Isabelle Margaill; Bruno Palmier; Didier Pruneau; Michel Plotkine; Catherine Marchand-Verrecchia
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

8.  Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats.

Authors:  Frank Cloutier; Brice Ongali; Maria M Campos; Gaétan Thibault; Witold Neugebauer; Réjean Couture
Journal:  Br J Pharmacol       Date:  2004-04-05       Impact factor: 8.739

9.  Knockout of p75NTR does not alter the viability of striatal neurons following a metabolic or excitotoxic injury.

Authors:  Rose Hanbury; Er-Yun Chen; Joanne Wuu; Jeffrey H Kordower
Journal:  J Mol Neurosci       Date:  2003-04       Impact factor: 3.444

10.  Serine-727 phosphorylation activates hypothalamic STAT-3 independently from tyrosine-705 phosphorylation.

Authors:  Andreas Breit; Valeria Besik; Hans Jürgen Solinski; Susanne Muehlich; Evi Glas; Stephen J Yarwood; Thomas Gudermann
Journal:  Mol Endocrinol       Date:  2015-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.